1. Home
  2. COEP vs GAME Comparison

COEP vs GAME Comparison

Compare COEP & GAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • GAME
  • Stock Information
  • Founded
  • COEP 2017
  • GAME 2011
  • Country
  • COEP United States
  • GAME United States
  • Employees
  • COEP N/A
  • GAME N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • GAME
  • Sector
  • COEP Health Care
  • GAME
  • Exchange
  • COEP Nasdaq
  • GAME Nasdaq
  • Market Cap
  • COEP 27.4M
  • GAME 74.8M
  • IPO Year
  • COEP N/A
  • GAME 2009
  • Fundamental
  • Price
  • COEP $11.15
  • GAME $0.95
  • Analyst Decision
  • COEP
  • GAME Strong Buy
  • Analyst Count
  • COEP 0
  • GAME 3
  • Target Price
  • COEP N/A
  • GAME $3.67
  • AVG Volume (30 Days)
  • COEP 56.9K
  • GAME 25.4M
  • Earning Date
  • COEP 08-15-2025
  • GAME 08-13-2025
  • Dividend Yield
  • COEP N/A
  • GAME N/A
  • EPS Growth
  • COEP N/A
  • GAME N/A
  • EPS
  • COEP N/A
  • GAME N/A
  • Revenue
  • COEP $62,874.00
  • GAME $99,579,536.00
  • Revenue This Year
  • COEP N/A
  • GAME $6.08
  • Revenue Next Year
  • COEP N/A
  • GAME $21.94
  • P/E Ratio
  • COEP N/A
  • GAME N/A
  • Revenue Growth
  • COEP N/A
  • GAME 77.06
  • 52 Week Low
  • COEP $2.31
  • GAME $0.50
  • 52 Week High
  • COEP $13.70
  • GAME $2.87
  • Technical
  • Relative Strength Index (RSI)
  • COEP 59.53
  • GAME 42.61
  • Support Level
  • COEP $11.30
  • GAME $1.47
  • Resistance Level
  • COEP $12.71
  • GAME $1.24
  • Average True Range (ATR)
  • COEP 0.89
  • GAME 0.28
  • MACD
  • COEP 0.18
  • GAME -0.10
  • Stochastic Oscillator
  • COEP 54.39
  • GAME 0.07

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About GAME GameSquare Holdings Inc.

GameSquare Holdings Inc is engaged in revolutionizing the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. It's next generation media, entertainment, and technology helps creators and maximize their brand partners' return on investment. Its purpose-built platform provides marketing and creative services, offers data and analytics solutions, and amplifies awareness through FaZe Clan.

Share on Social Networks: